Condition: Heart Arrest · Seizures · Status Epilepticus · Sponsor: University of California, San Francisco
Brain injury is the main cause of death and disability for patients surviving cardiac arrest resuscitation and seizures are diagnosed in up to a third of these patients. The investigators are proposing a pilot randomized placebo-controlled clinical trial to evaluate the safety and feasibility of perampanel use for post-cardiac arrest status epilepticus (PCARSE) prevention after cardiac arrest.
This description comes directly from the study's public registry record.
Edilberto Amorim, MD · 628-206-3203 · prosperstudy@ucsf.edu
Kevin Bao, BA · prosperstudy@ucsf.edu
Always discuss trial participation with your own doctor first.
| Zuckerberg San Francisco General Hospital | San Francisco, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06401707